Modulation of adenine nucleoside excretion and incorporation in adenosine deaminase deficient human lymphoma cells.
The availability of a human lymphoma cell line deficient in adenosine deaminase, adenosine kinase and methylthioadenosine phosphorylase enabled us to compare the effects of nucleoside transport inhibitors on the excretion of endogenously generated adenosine, deoxyadenosine and 5'-methylthioadenosine. The nucleoside transport inhibitors nitrobenzylthioinosine and dipyridamole blocked the efflux of adenosine, but not deoxyadenosine or 5'-methylthioadenosine. The inhibitors also prevented the uptake of exogenous adenosine, but not deoxyadenosine or 5'-methylthioadenosine, by human lymphoblasts. The results show (i) that the transport inhibitors modify adenine nucleoside efflux and influx similarly, and (ii) that the effects of the compounds on the excretion and uptake of these three physiologically important adenine nucleosides are distinctly different.
D000241:Adenosine / Q000031:analogs & derivatives / Q000378:metabolism*; D000243:Adenosine Deaminase / Q000172:deficiency*; D000248:Adenosine Kinase / Q000378:metabolism; D001692:Biological Transport; D002455:Cell Division; D002460:Cell Line; D003839:Deoxyadenosines / Q000378:metabolism*; D004176:Dipyridamole / Q000494:pharmacology; D006801:Humans; D008214:Lymphocytes / Q000378:metabolism; D008223:Lymphoma / Q000201:enzymology*; D009700:Nucleoside Deaminases / Q000172:deficiency*; D011683:Purine-Nucleoside Phosphorylase / Q000378:metabolism; D013868:Thioinosine / Q000031:analogs & derivatives / Q000494:pharmacology; D013872:Thionucleosides / Q000378:metabolism
D003839:Deoxyadenosines; D013872:Thionucleosides; D013868:Thioinosine; C008500:5'-methylthioadenosine; D004176:Dipyridamole; D011683:Purine-Nucleoside Phosphorylase; C021784:5'-methylthioadenosine phosphorylase; D000248:Adenosine Kinase; D009700:Nucleoside Deaminases; D000243:Adenosine Deaminase; C001789:4-nitrobenzylthioinosine; D000241:Adenosine